Robin Carhart-Harris

Dr. Carhart-Harris obtained a Ph.D. in Psychopharmacology from the University of Bristol in 2009 before moving to Imperial College London. There, he and colleagues completed multimodal human functional neuroimaging studies with LSD, psilocybin, MDMA and DMT, and clinical trials of psilocybin therapy for various disorders, including trials in depression, anorexia, and fibromyalgia syndrome. Carhart-Harris founded the Centre for Psychedelic Research at Imperial College London in April 2019 and set up the Carhart-Harris Lab at the University of California San Francisco in 2023, where he is the Ralph Metzner Distinguished Professor of Neurology and Psychiatry. His research program at UCSF focuses on the action of psychedelics and psychedelic-therapy. He has published widely, including in top-tier scientific and medical journals, and will soon release his first book, How Psychedelics Work.